Seres Therapeutics, Inc. Due to Related Parties, Current
Seres Therapeutics, Inc. (MCRB) had Due to Related Parties, Current of $24.96 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2023-05-09
- 2023-03-31: Due to Related Parties, Current $24.96M.
- 2022-12-31: Due to Related Parties, Current $34.77M.
- 2022-09-30: Due to Related Parties, Current $34.11M.
- 2022-06-30: Due to Related Parties, Current $33.06M.
| Period end | Due to Related Parties, Current |
|---|---|
| 2023-03-31 | $24.96M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $34.77M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $34.11M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $33.06M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $29.81M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $21.10M 10-K · filed 2023-03-07 |
| 2021-09-30 | $26.73M 10-Q · filed 2021-11-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |